Specific Activation of Retinoic Acid Receptors (RARs) and Retinoid X Receptors Reveals a Unique Role for RARγ in Induction of Differentiation and Apoptosis of S91 Melanoma Cells*

Retinoic acid (RA) and 9-cis-RA induce growth arrest and differentiation of S91 melanoma cells. RA activates retinoic acid receptors (RARs), whereas 9-cis-RA activates both RARs and retinoid X receptors (RXRs). Both classes of receptors function as ligand-dependent transcription factors. S91 melanoma cells contain mRNA for RXRα, RXRβ, RARα, RARγ, and RARβ in low levels. Among these, only RARβ gene transcription is induced by retinoids. However, at present the individual role(s) for each RXR and RAR isoform in these processes is unclear. We assessed the function of all isoforms in the S91 melanoma model by using RXR and RAR isoform-specific retinoids to study their effects on cell growth, RARβ expression, and differentiation. Activation of each of the endogenous RXR or RAR isoforms induces RARβ gene expression, and blocks cellular proliferation. However, only the RARγ-ligands cause additional differentiation toward a melanocytic phenotype, which coincides with substantial apoptosis well before morphological changes are apparent. Apoptosis is completely dependent on de novo protein synthesis but cannot be induced by changes in activities of AP-1, protein kinase C, and protein kinase A, nor can it be blocked by the presence of the antioxidant glutathione. These results argue against a specific role for RARβ, but suggest that RARγ has a critical role in a genetic switch between melanocytes and melanoma, and induction of ligand-dependent apoptosis.

[1]  T. Toda,et al.  A new group of conserved coactivators that increase the specificity of AP-1 transcription factors , 1996, Nature.

[2]  D. Kochhar,et al.  Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid. , 1996, Journal of medicinal chemistry.

[3]  M. Pfahl,et al.  The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal , 1996, Molecular and cellular biology.

[4]  M. Benito,et al.  Apoptosis induced by transforming growth factor-beta in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates. , 1996, The Journal of biological chemistry.

[5]  John Calvin Reed,et al.  Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.

[6]  Z. Dong,et al.  Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. , 1996, Cancer research.

[7]  B. Shroot,et al.  Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. , 1995, Journal of medicinal chemistry.

[8]  S. Ramalingam,et al.  Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. , 1995, Journal of the National Cancer Institute.

[9]  J. Ortonne,et al.  Mitogen-activated Protein Kinase Pathway and AP-1 Are Activated during cAMP-induced Melanogenesis in B-16 Melanoma Cells (*) , 1995, The Journal of Biological Chemistry.

[10]  K. R. Ely,et al.  Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. , 1995, Cancer research.

[11]  P. Chambon,et al.  Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Sheikh,et al.  p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. , 1995, Oncogene.

[13]  M. Haber,et al.  Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. , 1995, Oncogene.

[14]  A. Sugawara,et al.  Evidence that Retinoid X Receptors Mediate Retinoid-dependent Transcriptional Activation of the Retinoic Acid Receptor Gene in S91 Melanoma Cells (*) , 1995, The Journal of Biological Chemistry.

[15]  B. Neel,et al.  Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer , 1995, Molecular and cellular biology.

[16]  G. Shipley,et al.  Activation of retinoid X receptors induces apoptosis in HL-60 cell lines , 1995, Molecular and cellular biology.

[17]  J S Lee,et al.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.

[18]  E. Dmitrovsky,et al.  Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells. , 1995, Oncogene.

[19]  M. Dawson,et al.  Evidence for the Involvement of Retinoic Acid Receptor RAR-dependent Signaling Pathway in the Induction of Tissue Transglutaminase and Apoptosis by Retinoids (*) , 1995, The Journal of Biological Chemistry.

[20]  P. Chambon,et al.  RAR‐specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage‐independent cell proliferation. , 1995, The EMBO journal.

[21]  V. Pistoia,et al.  Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. , 1995, Cancer research.

[22]  S. Shack,et al.  Phenylacetate synergizes with retinoic acid in inducing the differentiation of human neuroblastoma cells , 1995, International journal of cancer.

[23]  P. Chambon,et al.  Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism , 1995, Molecular and cellular biology.

[24]  L. Gudas,et al.  Vitamin A, differentiation and cancer. , 1994, Current opinion in cell biology.

[25]  A. Fanjul,et al.  A new class of retinoids with selective inhibition of AP-1 inhibits proliferation , 1994, Nature.

[26]  W. Giaretti,et al.  Neuroblastoma cell apoptosis induced by the synthetic retinoid N‐(4‐hydroxyphenyl)retinamide , 1994, International journal of cancer.

[27]  M. Pfahl,et al.  A specific defect in the retinoic acid response associated with human lung cancer cell lines. , 1994, Cancer research.

[28]  P. Chambon,et al.  Retinoic Acid Receptor β2 (RARβ2) Null Mutant Mice Appear Normal , 1994 .

[29]  F. Unda,et al.  Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. , 1994, Experimental cell research.

[30]  Z. Shao,et al.  Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. , 1994, The Journal of biological chemistry.

[31]  U. Veronesi,et al.  N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. , 1994, Journal of the National Cancer Institute.

[32]  L. Gudas Retinoids and vertebrate development. , 1994, The Journal of biological chemistry.

[33]  C. Glass Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. , 1994, Endocrine reviews.

[34]  Randal K. Wada,et al.  Retinoic acid up‐regulates nuclear retinoic acid receptor‐α expression in human neuroblastoma cells , 1994, International journal of cancer.

[35]  O. Gandrillon,et al.  c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene. , 1994, Oncogene.

[36]  M. Haber,et al.  Regulation of retinoic acid receptor alpha expression in human neuroblastoma cell lines and tumor tissue. , 1994, Anticancer research.

[37]  H. Masutani,et al.  Marked apoptosis of human myelomonocytic leukemia cell line P39: significance of cellular differentiation. , 1994, Leukemia.

[38]  E. Dmitrovsky,et al.  Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas. , 1994, Oncogene.

[39]  S. Ménard,et al.  N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. , 1993, Cancer research.

[40]  P. Chambon,et al.  The patterns of binding of RAR, RXR and TR homo‐ and heterodimers to direct repeats are dictated by the binding specificites of the DNA binding domains. , 1993, The EMBO journal.

[41]  P. Chambon,et al.  Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Dawson,et al.  Correlation of the ability of retinoids to inhibit promoter-induced anchorage-independent growth of JB6 mouse epidermal cells with their activation of retinoic acid receptor gamma. , 1993, Cancer letters.

[43]  P. Chambon,et al.  High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Pratt,et al.  Retinoic acid fails to induce expression of Hox genes in differentiation-defective murine embryonal carcinoma cells carrying a mutant gene for alpha retinoic acid receptor. , 1993, Differentiation; research in biological diversity.

[45]  P. Chambon,et al.  Function of retinoic acid receptor γ in the mouse , 1993, Cell.

[46]  R. Jaenisch,et al.  Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  P. Chambon,et al.  All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs , 1992, Cell.

[49]  P. Chambon,et al.  Multiplicity generates diversity in the retinoic acid signalling pathways. , 1992, Trends in biochemical sciences.

[50]  P. Chambon,et al.  Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors , 1992, Cell.

[51]  M. Annicchiarico-Petruzzelli,et al.  Phenotype‐specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis , 1992, International journal of cancer.

[52]  K. Robertson,et al.  Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells , 1992, Molecular and cellular biology.

[53]  L. Gudas Retinoids, retinoid-responsive genes, cell differentiation, and cancer. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[54]  J. Lehmann,et al.  Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid , 1992, Nature.

[55]  B. Shroot,et al.  Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma. , 1992, Biochemical and biophysical research communications.

[56]  T. Bugge,et al.  RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. , 1992, The EMBO journal.

[57]  E. Appella,et al.  H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. , 1992, The EMBO journal.

[58]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[59]  M. Pfahl,et al.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.

[60]  Philippe Kastner,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.

[61]  Gregor Eichele,et al.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor , 1992, Cell.

[62]  J. Grippo,et al.  9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα , 1992, Nature.

[63]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[64]  R. Evans,et al.  Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. , 1991, Trends in genetics : TIG.

[65]  L. M. Luca,et al.  Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. , 1991 .

[66]  C. Glass,et al.  Regulation of gene expression by retinoic acid receptors. , 1991, DNA and cell biology.

[67]  B. Shroot,et al.  Selective high affinity retinoic acid receptor alpha or beta-gamma ligands. , 1991, Molecular pharmacology.

[68]  D. Sugarbaker,et al.  High frequency of retinoic acid receptor beta abnormalities in human lung cancer. , 1991, Oncogene.

[69]  K. Umesono,et al.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR , 1991, Cell.

[70]  Clifford J. Tabin,et al.  Retinoids, homeoboxes, and growth factors: Toward molecular models for limb development , 1991, Cell.

[71]  W. Wahli,et al.  Superfamily of steroid nuclear receptors: positive and negative regulators of gene expression , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  J. Lehmann,et al.  A Retinoic Acid Receptor-Specific Element Controls the Retinoic Acid Receptor-β Promoter , 1990 .

[73]  J. Latham,et al.  The biological activity of retinoids in melanoma cells , 1990, FEBS letters.

[74]  P. Chambon,et al.  Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. , 1990, Molecular endocrinology.

[75]  R. Evans,et al.  Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[76]  S. Collins,et al.  Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha) , 1990, Molecular and cellular biology.

[77]  T G Cotter,et al.  HL‐60 cells induced to differentiate towards neutrophils subsequently die via apoptosis , 1990, Clinical and experimental immunology.

[78]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[79]  Y. Hashimoto,et al.  Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. , 1988, Journal of medicinal chemistry.

[80]  R. Lotan,et al.  Enhancement of melanotic expression in cultured mouse smelanoma cells by retinoids , 1981, Journal of cellular physiology.

[81]  R. Lotan,et al.  Characterization of the inhibitory effects of retinoids on the in vitro growth of two malignant murine melanomas. , 1978, Journal of the National Cancer Institute.

[82]  D. Schadendorf,et al.  Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro. , 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[83]  M. McBurney,et al.  Retinoids and cancer: a basis for differentiation therapy. , 1993, Cancer investigation.

[84]  B. Shroot,et al.  Selective synthetic ligands for human nuclear retinoic acid receptors. , 1992, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[85]  R. Lotan,et al.  Retinoid-sensitive cells and cell lines. , 1990, Methods in enzymology.

[86]  M. Rocher,et al.  Biological activity of retinoids correlates with affinity for nuclear receptors but not for cytosolic binding protein. , 1988, Skin pharmacology : the official journal of the Skin Pharmacology Society.